Plain-English translation of NCT06719427 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing repetitive transcranial magnetic stimulation (rTMS)—a non-invasive procedure that uses magnetic pulses to stimulate specific areas of the brain involved in mood regulation—for people with major depression that hasn't responded well to other treatments. Researchers will measure brain electrical activity before, during, and after the treatment to understand how it works and which brain changes predict who will improve. The study will also compare two different schedules for continuing treatment after the initial intensive phase.
Many people with depression don't get better with medication alone, and doctors need better ways to predict who will respond to this treatment and how to maintain improvements long-term. By studying the brain's electrical activity, researchers hope to understand how the treatment works and find the best way to keep people well after their initial course of therapy.
You likely qualify if…
You likely don't qualify if…
You will receive an intensive five-day course of magnetic brain stimulation targeted to a specific area involved in mood regulation. Throughout the study, you'll complete mood questionnaires and have your brain's electrical activity recorded using a non-invasive headset at multiple time points. If the treatment helps, you'll enter a follow-up phase where you'll receive either clustered treatments (five sessions over two days) or gradually spaced-out sessions over several months, while researchers monitor how you're doing.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Canada